Kiniksa Pharmaceuticals International, plc SEC filings KNSA
Kiniksa Pharmaceuticals International, plc has 776 filings in SEC EDGAR's recent list, going back to Feb 27, 2018. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Feb 24, 2026 | — |
| S-8 | Employee stock plan registration | Feb 25, 2025 | — |
| S-3 | Shelf registration | Jun 28, 2024 | — |
| S-8 POS | Filing | Jun 28, 2024 | — |
| S-8 POS | Filing | Jun 28, 2024 | — |
| S-8 POS | Filing | Jun 28, 2024 | — |
| S-8 POS | Filing | Jun 28, 2024 | — |
| S-8 POS | Filing | Jun 28, 2024 | — |
| S-8 POS | Filing | Jun 28, 2024 | — |
| POS AM | Filing | Jun 28, 2024 | — |
| POS AM | Filing | Jun 28, 2024 | — |
| S-8 | Employee stock plan registration | Feb 28, 2024 | — |
| S-8 | Employee stock plan registration | Mar 2, 2023 | — |
| S-3 | Shelf registration | May 6, 2022 | — |
| S-3 | Shelf registration | May 6, 2022 | — |
| S-8 | Employee stock plan registration | Feb 24, 2022 | — |
| S-8 | Employee stock plan registration | Feb 25, 2021 | — |
| S-3 | Shelf registration | Sep 8, 2020 | — |
| 424B5 | Prospectus supplement | Jul 23, 2020 | — |
| 424B5 | Prospectus supplement | Jul 20, 2020 | — |
| S-3 | Shelf registration | May 21, 2020 | — |
| 424B5 | Prospectus supplement | May 15, 2020 | — |
| 424B5 | Prospectus supplement | May 14, 2020 | — |
| S-8 | Employee stock plan registration | Apr 7, 2020 | — |
| S-3 | Shelf registration | Jun 3, 2019 | — |
| 424B4 | Prospectus | Feb 1, 2019 | — |
| FWP | Free writing prospectus | Jan 31, 2019 | — |
| FWP | Free writing prospectus | Jan 28, 2019 | — |
| S-1 | Registration statement | Jan 28, 2019 | — |
| S-8 | Employee stock plan registration | May 24, 2018 | — |
| 424B4 | Prospectus | May 24, 2018 | — |
| S-1MEF | Filing | May 23, 2018 | — |
| S-1/A | Amended registration statement | May 18, 2018 | — |
| S-1/A | Amended registration statement | May 14, 2018 | — |
| S-1 | Registration statement | Apr 27, 2018 | — |
Showing 35 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KNSA (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- London
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1730430
- Former names
- Kiniksa Pharmaceuticals, Ltd. (until Jun 28, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.